TARA icon

Protara Therapeutics

16 hedge funds and large institutions have $2.9M invested in Protara Therapeutics in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$231K
2 +$98K
3 +$38.5K
4
A
Abingworth
United Kingdom
+$36.3K
5
Renaissance Technologies
Renaissance Technologies
New York
+$22K

Top Sellers

1 -$82K
2 -$23K
3 -$17.1K
4
BFM
Boothbay Fund Management
New York
-$15K
5
UBS Group
UBS Group
Switzerland
-$6.86K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$879K
2
$832K
3
$346K
4
$140K
5
$140K
6
$138K
7
$132K
8
$84K
9
$75K
10
$63K
11
$36K
12
$19K
13
$7K
14
$6K
15
$3K
16
$2K
17
18
19
20
21
22